+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Global Forecast 2025-2030- Product Image
Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674401
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Osteoarthritis Therapeutics Market grew from USD 7.90 billion in 2023 to USD 8.69 billion in 2024. It is expected to continue growing at a CAGR of 10.39%, reaching USD 15.78 billion by 2030.

The osteoarthritis therapeutics market encompasses pharmaceutical and non-pharmaceutical interventions aimed at treating symptoms and slowing disease progression. This includes analgesics, corticosteroids, hyaluronic acid injections, and disease-modifying osteoarthritis drugs (DMOADs). The necessity for these therapeutics is driven by the high prevalence of osteoarthritis, especially among the aging population, and the increasing awareness of joint health. Applications primarily target reducing pain, improving joint function, and enhancing quality of life for patients. End-users include hospitals, clinics, and home care settings. Market growth is primarily influenced by advancements in biotechnology, increasing R&D activities, and the rising demand for minimally invasive treatments. The latest potential opportunities lie in the development of personalized medicine and biologics tailored to individual patient profiles, presenting significant growth potential. To capitalize on these opportunities, companies should invest in advanced research technologies such as CRISPR and AI for drug discovery. However, market growth is challenged by high drug development costs, stringent regulatory requirements, and unpredictable patient responses to treatments. There's also limited availability of curative treatments, which narrows therapeutic options to mainly symptom management. Innovations in gene therapy, stem cell research, and regenerative medicine are possible areas for growth, aiming to develop treatments that modify the disease course rather than just providing symptomatic relief. The nature of the market is highly competitive with significant investment from key pharmaceutical players alongside emerging biotech firms. Collaboration between academia and industry, alongside public-private partnerships, could further spur research momentum. Recommendations include focusing on partnerships with tech firms to leverage big data analytics in predicting disease outcomes, thereby improving patient stratification. Additionally, enhancing distribution networks to improve accessibility in emerging markets can help in capitalizing on the growing demand.

Understanding Market Dynamics in the Osteoarthritis Therapeutics Market

The Osteoarthritis Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of osteoarthritis across the globe
    • Potential demand for minimally invasive surgical procedures
    • Growing geriatric population coupled with increasing sports injury worldwide
  • Market Restraints
    • Concern associated with adverse effects of NSAID
  • Market Opportunities
    • Emerging pharmaceuticals therapies for osteoarthritis
    • Ongoing research and development in the osteoarthritis field
    • Increasing governments supports towards the osteoarthritis treatment
    • Rising healthcare expenditure per capita income in the emerging economies
  • Market Challenges
    • Rapid adoption of non-drug pain management therapies

Exploring Porter’s Five Forces for the Osteoarthritis Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Osteoarthritis Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Osteoarthritis Therapeutics Market

External macro-environmental factors deeply influence the performance of the Osteoarthritis Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Osteoarthritis Therapeutics Market

The Osteoarthritis Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Osteoarthritis Therapeutics Market

The Osteoarthritis Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Osteoarthritis Therapeutics Market

The Osteoarthritis Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteoarthritis Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Almatica Pharma LLC, Anika Therapeutics, Inc., Assertio Therapeutics, Inc., Atnahs Pharma UK Limited, Bayer AG, Bioventus, Eli Lilly and Company, Ferring B.V., Fidia Farmaceutici s.p.a., Flexion Therapeutics, Inc., GlaxoSmithKline PLC, Hanmi Pharm. Co., Ltd., Horizon Therapeutics PLC, and Kitov Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Osteoarthritis Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Anatomy
    • Hand Osteoarthritis
    • Hip Osteoarthritis
    • Knee Osteoarthritis
    • Small Joint Osteoarthritis
  • Drug Type
    • Analgesics
      • Acetaminophen
      • Duloxetine
    • Corticosteroids
    • Nonsteroidal Anti-inflammatory Drugs
      • Aspirin
      • Diclofenac
      • Ibuprofen
      • Naproxen
    • Viscosupplementation Agents
  • Route of Administration
    • Oral Route
    • Parenteral Route
    • Topical Route
  • Purchasing Pattern
    • Over-the-Counter Drugs
    • Prescription Drugs
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of osteoarthritis across the globe
5.1.1.2. Potential demand for minimally invasive surgical procedures
5.1.1.3. Growing geriatric population coupled with increasing sports injury worldwide
5.1.2. Restraints
5.1.2.1. Concern associated with adverse effects of NSAID
5.1.3. Opportunities
5.1.3.1. Emerging pharmaceuticals therapies for osteoarthritis
5.1.3.2. Ongoing research and development in the osteoarthritis field
5.1.3.3. Increasing governments supports towards the osteoarthritis treatment
5.1.3.4. Rising healthcare expenditure per capita income in the emerging economies
5.1.4. Challenges
5.1.4.1. Rapid adoption of non-drug pain management therapies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Osteoarthritis Therapeutics Market, by Anatomy
6.1. Introduction
6.2. Hand Osteoarthritis
6.3. Hip Osteoarthritis
6.4. Knee Osteoarthritis
6.5. Small Joint Osteoarthritis
7. Osteoarthritis Therapeutics Market, by Drug Type
7.1. Introduction
7.2. Analgesics
7.2.1. Acetaminophen
7.2.2. Duloxetine
7.3. Corticosteroids
7.4. Nonsteroidal Anti-inflammatory Drugs
7.4.1. Aspirin
7.4.2. Diclofenac
7.4.3. Ibuprofen
7.4.4. Naproxen
7.5. Viscosupplementation Agents
8. Osteoarthritis Therapeutics Market, by Route of Administration
8.1. Introduction
8.2. Oral Route
8.3. Parenteral Route
8.4. Topical Route
9. Osteoarthritis Therapeutics Market, by Purchasing Pattern
9.1. Introduction
9.2. Over-the-Counter Drugs
9.3. Prescription Drugs
10. Osteoarthritis Therapeutics Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Americas Osteoarthritis Therapeutics Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Osteoarthritis Therapeutics Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Osteoarthritis Therapeutics Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2030 (%)
FIGURE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. OSTEOARTHRITIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. OSTEOARTHRITIS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. OSTEOARTHRITIS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OSTEOARTHRITIS THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SMALL JOINT OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DULOXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY VISCOSUPPLEMENTATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PARENTERAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TOPICAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 59. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 61. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 62. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 64. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 71. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 96. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 98. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 101. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 103. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 105. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 106. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 108. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 117. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 119. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 120. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 122. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 159. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 161. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 162. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 164. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 180. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 183. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 184. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 186. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 188. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 190. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 193. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 200. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 202. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 204. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 205. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 207. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 209. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 211. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 212. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 214. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 223. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 225. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 226. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 228. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 244. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 249. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 251. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 253. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 256. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 258. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 259. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 260. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 261. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 263. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 286. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 287. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 291. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANA

Companies Mentioned

The leading players in the Osteoarthritis Therapeutics Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Almatica Pharma LLC
  • Anika Therapeutics, Inc.
  • Assertio Therapeutics, Inc.
  • Atnahs Pharma UK Limited
  • Bayer AG
  • Bioventus
  • Eli Lilly and Company
  • Ferring B.V.
  • Fidia Farmaceutici s.p.a.
  • Flexion Therapeutics, Inc.
  • GlaxoSmithKline PLC
  • Hanmi Pharm. Co., Ltd.
  • Horizon Therapeutics PLC
  • Kitov Pharmaceuticals Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.78 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Osteoarthritis Therapeutics - Global Strategic Business Report - Product Image

Osteoarthritis Therapeutics - Global Strategic Business Report

  • Report
  • 84 Pages
  • Global
From
Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Image

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • 137 Pages
  • Global
From
Osteoarthritis Therapeutics Market 2024-2028 - Product Image

Osteoarthritis Therapeutics Market 2024-2028

  • Report
  • 177 Pages
  • Global
From
Osteoarthritis - Market Insight, Epidemiology and Market Forecast - 2032 - Product Image

Osteoarthritis - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • 289 Pages
  • Global
From

About the Osteoarthritis Drug Market

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs). The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.